Ameritas Investment Partners’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-26,724
| Closed | -$2.65M | – | 3097 |
|
|
2019
Q3 | $2.65M | Sell |
26,724
-95
| -0.4% | -$9.03K | 0.12% | 166 |
|
|
2019
Q2 | $2.48M | Buy |
26,819
+86
| +0.3% | +$8.17K | 0.11% | 183 |
|
|
2019
Q1 | $2.52M | Buy |
26,733
+301
| +1% | +$26.3K | 0.12% | 168 |
|
|
2018
Q4 | $1.69M | Sell |
26,432
-5,056
| -16% | -$373K | 0.09% | 249 |
|
|
2018
Q3 | $2.82M | Sell |
31,488
-2,561
| -8% | -$226K | 0.13% | 157 |
|
|
2018
Q2 | $2.7M | Sell |
34,049
-15,288
| -31% | -$1.27M | 0.13% | 154 |
|
|
2018
Q1 | $4.4M | Sell |
49,337
-5,372
| -10% | -$516K | 0.21% | 70 |
|
|
2017
Q4 | $6.03M | Sell |
54,709
-3,355
| -6% | -$379K | 0.28% | 51 |
|
|
2017
Q3 | $8.25M | Sell |
58,064
-95
| -0.2% | -$12.9K | 0.39% | 31 |
|
|
2017
Q2 | $7.55M | Sell |
58,159
-19
| -0% | -$2.33K | 0.37% | 33 |
|
|
2017
Q1 | $7.24M | Sell |
58,178
-2,832
| -5% | -$339K | 0.36% | 36 |
|
|
2016
Q4 | $7.06M | Buy |
61,010
+6,485
| +12% | +$722K | 0.36% | 37 |
|
|
2016
Q3 | $5.7M | Sell |
54,525
-10,403
| -16% | -$1.13M | 0.31% | 40 |
|
|
2016
Q2 | $6.4M | Buy |
64,928
+1,710
| +3% | +$177K | 0.42% | 38 |
|
|
2016
Q1 | $6.33M | Buy |
63,218
+7,974
| +14% | +$821K | 0.42% | 38 |
|
|
2015
Q4 | $6.61M | Buy |
55,244
+26,060
| +89% | +$3.01M | 0.45% | 34 |
|
|
2015
Q3 | $3.16M | Sell |
29,184
-80
| -0.3% | -$9.93K | 0.23% | 80 |
|
|
2015
Q2 | $3.39M | Hold |
29,264
| – | – | 0.22% | 90 |
|
|
2015
Q1 | $3.37M | Sell |
29,264
-287
| -1% | -$34.3K | 0.22% | 91 |
|
|
2014
Q4 | $3.31M | Buy |
29,551
+1,391
| +5% | +$147K | 0.23% | 94 |
|
|
2014
Q3 | $2.67M | Sell |
28,160
-2,214
| -7% | -$200K | 0.19% | 119 |
|
|
2014
Q2 | $2.61M | Sell |
30,374
-1,644
| -5% | -$125K | 0.19% | 120 |
|
|
2014
Q1 | $2.23M | Sell |
32,018
-34,214
| -52% | -$2.71M | 0.18% | 142 |
|
|
2013
Q4 | $5.59M | Buy |
66,232
+15,922
| +32% | +$1.26M | 0.45% | 36 |
|
|
2013
Q3 | $3.88M | Buy |
50,310
+14,990
| +42% | +$1.05M | 0.36% | 50 |
|
|
2013
Q2 | $2.07M | Buy |
+35,320
| New | +$2.13M | 0.57% | 46 |
|
Other funds holding CELG
FP
HCM
PCMC
WCG
Ameritas Investment Partners's CELG Position: Q4 2019 in Review
Ameritas Investment Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 26,724 shares — an estimated $2.65M sold.
Ameritas Investment Partners first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $8.25M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.
- Ameritas Investment Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
- Ameritas Investment Partners sold 26,724 Celgene Corp shares in Q4 2019, an estimated $2.65M.
- Ameritas Investment Partners first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
- Ameritas Investment Partners's Celgene Corp position peaked at $8.25M in Q3 2017.
- 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.
Based on Ameritas Investment Partners's 13F filing for Q4 2019, filed 13 Feb 2020.